FIELD: chemistry.
SUBSTANCE: invention relates to cortistatin analogues. Compounds of the present invention are peptide ligands.
EFFECT: invention can be used in diagnosis, prevention or treatment of pathologies in which are expressed receptors capable of binding to cortistatin, which are specific for other molecules or common to them, such as somatostatin and / or ghrelin (GHSR), are additionally more stable in serum than cortistatin.
15 cl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
PEPTIDE LIGANDS OF SOMATOSTATINE RECEPTORS | 2010 |
|
RU2525468C2 |
SOMATOSTATINE PEPTIDES | 1996 |
|
RU2160741C2 |
CHIMERIC ANALOGS OF SOMATOSTATIN-DOPAMINE | 2002 |
|
RU2277539C2 |
SOMATOSTATIN ANALOGUES | 2001 |
|
RU2287533C2 |
GLYCOSYLATED POLYPEPTIDES AND MEDICINAL COMPOSITIONS CONTAINING THESE POLYPEPTIDES | 2012 |
|
RU2624034C2 |
LOCAL EYE PEPTIDE COMPOSITION | 2010 |
|
RU2561585C2 |
GLYCOSYLATED POLYPEPTIDES AND MEDICINAL COMPOSITIONS CONTAINING THESE POLYPEPTIDES | 2012 |
|
RU2627184C2 |
SOMATOSTATIN ANTAGONISTS | 2002 |
|
RU2328504C2 |
PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2355418C2 |
SOMATOSTATIN ANTAGONISTS | 2002 |
|
RU2263678C2 |
Authors
Dates
2019-01-28—Published
2014-09-17—Filed